Literature DB >> 17473446

Mouse equilibrative nucleoside transporter 2 (mENT2) transports nucleosides and purine nucleobases differing from human and rat ENT2.

Katsuhito Nagai1, Kazuki Nagasawa, Yoji Kyotani, Natsuko Hifumi, Sadaki Fujimoto.   

Abstract

Several mammalian nucleoside transporters have been identified at the molecular level. Human and rat equilibrative nucleoside transporter 2 (hENT2 and rENT2, respectively) was previously reported to have the dual ability of transporting both nucleosides and nucleobases. In the present study, we characterized the transport of a variety of nucleosides and nucleobases via recombinant mouse ENT2 (mENT2). Cloned mENT2 mediated the uptake of nucleosides and purine nucleobases, but not pyrimidine nucleobases. The mENT2-mediated uptake of adenosine was significantly inhibited by nucleosides and nucleobases, irrespective of purine and pyrimidine. The K(m) values for the uptake of nucleosides and purine nucleobases mediated by mENT2 varied between 1.24 and 16.3 microM, and the transport clearances of adenosine and hypoxanthine via the transporter were greater than those of other substrates. Therefore, we concluded that mENT2 is nucleoside and purine nucleobase transporter, and pyrimidine nucleobases are blockers for the transporter, differing from hENT2 and rENT2 that were reported to also transport pyrimidine nucleobases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17473446     DOI: 10.1248/bpb.30.979

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

Review 1.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

2.  Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent.

Authors:  Anren Song; Yujin Zhang; Leng Han; Gennady G Yegutkin; Hong Liu; Kaiqi Sun; Angelo D'Alessandro; Jessica Li; Harry Karmouty-Quintana; Takayuki Iriyama; Tingting Weng; Shushan Zhao; Wei Wang; Hongyu Wu; Travis Nemkov; Andrew W Subudhi; Sonja Jameson-Van Houten; Colleen G Julian; Andrew T Lovering; Kirk C Hansen; Hong Zhang; Mikhail Bogdanov; William Dowhan; Jianping Jin; Rodney E Kellems; Holger K Eltzschig; Michael Blackburn; Robert C Roach; Yang Xia
Journal:  Nat Commun       Date:  2017-02-07       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.